|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| Choose application no.
|
|
| |
|
|
| Application no. and date | 04806159.2 (espacenet) (Federated) (European Patent Register), 20041218 | | Patent/reg. no. and date | DK/EP 1699782, 20100623 | | Publication date | 20060913 | | Priority no. and date | GB 0330002, 20031224 | | EP pub. no. and date |
EP 1699782 20060913 | | Effective date | | | Applicant/owner | AstraZeneca AB,
S-151 85 Södertälje, SE | | Applicant ref. no. | AST 101157-1X | | Inventor | McCABE, James, AstraZeneca
Charter Way
Macclesfield,
Cheshire SK10 2NA, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 35/00 (2006.01) , C07D 403/12 (2006.01) | | Title | Maleatsalte af et quinazolinderivat, hvilke maleatsalte er anvendelige som et antiangiogent middel | | Int. application no. | GB2004005359 | | Int. publication no. | WO2005061488 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
